How CathWorks Drew from Many Voices to Improve Cardiac Care, Build a Quick Path to Acquisition
In this episode of DeviceTalks Weekly, CathWorks CEO Ramin Mousavi explains how the company built a surprisingly fast path to acquisition.
Founded in 2013, the startup was forced to go back to the drawing board. By incorporating LLMs and other advances, CathWorks developed a better way to diagnose heart disease—leading to a strategic investment from Medtronic in 2022 and a full acquisition announced this week.
Mousavi also shares his personal path into MedTech, including the unlikely story of an Iranian-American leading an Israel-based startup. In a conversation with Host Tom Salemi, he reflects on how employees kept the company’s mission front and center through constant change.
In this week’s FOMO, Managing Editor Kayleen Brown draws on her own experience with Type 2 diabetes to explore how Dexcom is using data and AI. She speaks with Girish Naganathan, EVP and Chief Technology Officer at Dexcom.
Plus, MassDevice Editor Chris Newmarker delivers Newmarker’s Newsmakers, featuring Medtronic, Siemens Healthineers, Stryker, Boston Scientific, and Applied Medical.
Thank you for listening to DeviceTalks Weekly!
***
Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.
Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe
